Debt-to-equity of Sonoma Pharmaceuticals, Inc. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Sonoma Pharmaceuticals, Inc. quarterly Debt-to-equity in % history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • Sonoma Pharmaceuticals, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 256%, a 58% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Sonoma Pharmaceuticals, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 256% +94% +58% 31 Dec 2025
Q3 2025 226% +81% +56% 30 Sep 2025
Q2 2025 198% +56% +40% 30 Jun 2025
Q1 2025 179% +50% +39% 31 Mar 2025
Q4 2024 161% +43% +36% 31 Dec 2024
Q3 2024 145% +19% +15% 30 Sep 2024
Q2 2024 141% +22% +18% 30 Jun 2024
Q1 2024 129% +10% +8.7% 31 Mar 2024
Q4 2023 119% -3.1% -2.5% 31 Dec 2023
Q3 2023 126% +24% +23% 30 Sep 2023
Q2 2023 119% +28% +31% 30 Jun 2023
Q1 2023 118% +18% +18% 31 Mar 2023
Q4 2022 122% +13% +12% 31 Dec 2022
Q3 2022 102% +2.8% +2.9% 30 Sep 2022
Q2 2022 91% -2% -2.2% 30 Jun 2022
Q1 2022 101% +27% +36% 31 Mar 2022
Q4 2021 109% +38% +52% 31 Dec 2021
Q3 2021 99% +27% +37% 30 Sep 2021
Q2 2021 93% +21% +28% 30 Jun 2021
Q1 2021 74% +7.9% +12% 31 Mar 2021
Q4 2020 72% +21% +43% 31 Dec 2020
Q3 2020 72% +28% +64% 30 Sep 2020
Q2 2020 73% +35% +90% 30 Jun 2020
Q1 2020 66% +32% +93% 31 Mar 2020
Q4 2019 50% +21% +73% 31 Dec 2019
Q3 2019 44% +15% +51% 30 Sep 2019
Q2 2019 38% +11% +40% 30 Jun 2019
Q1 2019 34% +9.7% +39% 31 Mar 2019
Q4 2018 29% +6.5% +29% 31 Dec 2018
Q3 2018 29% +8.5% +41% 30 Sep 2018
Q2 2018 27% +4.6% +20% 30 Jun 2018
Q1 2018 25% -2.1% -7.7% 31 Mar 2018
Q4 2017 23% -9.6% -30% 31 Dec 2017
Q3 2017 21% -20% -49% 30 Sep 2017
Q2 2017 23% -12% -34% 30 Jun 2017
Q1 2017 27% -3.9% -13% 31 Mar 2017
Q4 2016 32% +4.6% +17% 31 Dec 2016
Q3 2016 41% +9.7% +31% 30 Sep 2016
Q2 2016 35% +0.56% +1.6% 30 Jun 2016
Q1 2016 30% -9.2% -23% 31 Mar 2016
Q4 2015 28% -24% -47% 31 Dec 2015
Q3 2015 31% -32% -51% 30 Sep 2015
Q2 2015 34% -61% -64% 30 Jun 2015
Q1 2015 40% -116% -74% 31 Mar 2015
Q4 2014 52% -208% -80% 31 Dec 2014
Q3 2014 63% -222% -78% 30 Sep 2014
Q2 2014 95% -323% -77% 30 Jun 2014
Q1 2014 155% -418% -73% 31 Mar 2014
Q4 2013 260% -1675% -87% 31 Dec 2013
Q3 2013 286% +5004% 30 Sep 2013
Q2 2013 419% +7387% 30 Jun 2013
Q1 2013 573% +8117% 31 Mar 2013
Q4 2012 1935% +398% +26% 31 Dec 2012
Q3 2012 -4719% 30 Sep 2012
Q2 2012 -6969% 30 Jun 2012
Q1 2012 -7543% 31 Mar 2012
Q4 2011 1537% 31 Dec 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.